title: Corrigendum: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents.
authors.forename: Mitchell L
authors.initials: ML
authors.lastname: Shiffman
authors.forename: Vinod
authors.initials: V
authors.lastname: Rustgi
authors.forename: Michael
authors.initials: M
authors.lastname: Bennett
authors.forename: Xavier
authors.initials: X
authors.lastname: Forns
authors.forename: Tarik
authors.initials: T
authors.lastname: Asselah
authors.forename: Ramon Planas
authors.initials: RP
authors.lastname: Vila
authors.forename: Li
authors.initials: L
authors.lastname: Liu
authors.forename: Marcos
authors.initials: M
authors.lastname: Pedrosa
authors.forename: Jonathan
authors.initials: J
authors.lastname: Moller
authors.forename: Nancy
authors.initials: N
authors.lastname: Reau